Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind crossover study of controlled-release versus immediate-release carvedilol in primary hypertension
2006-006534-17Phase 2Terminated
- Sponsor
- Egalet
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of carvedilol in essential hypertension (2 arms), sponsored by Egalet. Primary endpoint: Primary efficacy endpoint. Started Jan 2007; status: terminated.
02
Drugs
carvedilol
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2006-006534-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006534-17.